ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.52
-1.13%
US Tech 100
20,263.20
-1.69%
S&P 500
5,827.04
-1.54%
US Dollar vs CAD
1.44361
0.13%
Bitcoin
93,575.67
-0.97%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Illumina Inc (I1LM34) Share Price

Illumina Inc

Illumina Inc (I1LM34)

BOV
166.01
0.00
(0.00%)
Closed January 13 2:55PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
166.01
Bid
0.00
Ask
230.00
Volume
-
0.00 Day's Range 0.00
108.57 52 Week Range 178.38
Market Cap
26.362B
Previous Close
166.01
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
80
Shares Outstanding
158,800,000
Dividend Yield
-
PE Ratio
-18.70
Earnings Per Share (EPS)
-7.31
Revenue
4.5B
Net Profit
-1.16B

About Illumina Inc

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.illumina.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Illumina Inc is listed in the Lab Analytical Instruments sector of the Brazil Bovespa Exchange with ticker I1LM34. The last closing price for Illumina was R$166.01. Over the last year, Illumina shares have traded in a share price range of R$ 108.57 to R$ 178.38.

Illumina currently has 158,800,000 shares outstanding. The market capitalization of Illumina is R$26.36 billion. Illumina has a price to earnings ratio (PE ratio) of -18.70.

Ask ADVFN Intelligence (AI)

I1LM34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
400166.01166.01166.0150166.01DR
121.651.00389389146164.36178.38162.6980173.07753443DR
2644.0136.0737704918122178.3812286151.88145182DR
5230.2122.2459499264135.8178.38108.5789140.5034613DR
156-234.39-58.538961039400.4467.8190153234.87824794DR
260-81.18-32.8411343501247.1958690229359.63594946DR

I1LM34 - Frequently Asked Questions (FAQ)

What is the current Illumina share price?
The current share price of Illumina is R$ 166.01
How many Illumina shares are in issue?
Illumina has 158,800,000 shares in issue
What is the market cap of Illumina?
The market capitalisation of Illumina is BRL 26.36B
What is the 1 year trading range for Illumina share price?
Illumina has traded in the range of R$ 108.57 to R$ 178.38 during the past year
What is the PE ratio of Illumina?
The price to earnings ratio of Illumina is -18.7
What is the cash to sales ratio of Illumina?
The cash to sales ratio of Illumina is 4.82
What is the reporting currency for Illumina?
Illumina reports financial results in USD
What is the latest annual turnover for Illumina?
The latest annual turnover of Illumina is USD 4.5B
What is the latest annual profit for Illumina?
The latest annual profit of Illumina is USD -1.16B
What is the registered address of Illumina?
The registered address for Illumina is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Illumina website address?
The website address for Illumina is www.illumina.com
Which industry sector does Illumina operate in?
Illumina operates in the LAB ANALYTICAL INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMAR11Lojas Marisa S.A.
R$ 0.69
(13.11%)
4.1k
IFCM3Infracommerce Caxaas S.A.
R$ 0.09
(12.50%)
4.88M
MWET4Wetzel Sa (ex Metalurgica Wetzel Sa)
R$ 10.80
(8.65%)
3k
FICT3Fictor Alimentos S.A.
R$ 3.13
(7.93%)
80k
OIBR3Oi
R$ 1.47
(6.52%)
8.74M
GPAR3Companhia Celg de Participacoes Celgpar
R$ 31.40
(-33.19%)
100
CAML3Camil Alimentos, S.A.
R$ 4.91
(-14.46%)
6.51M
PSVM11PORTO SUDESTE VM SA
R$ 4.46
(-10.44%)
100
IGTI4Iguatemi S.A.
R$ 7.50
(-8.54%)
700
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.43
(-8.16%)
1.15M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.20
(-2.65%)
48.51M
BBDC4Bco Bradesco Sa
R$ 11.18
(-1.24%)
46.31M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.94
(0.271444%)
40.33M
ABEV3Ambev SA
R$ 11.16
(-2.11%)
31.28M
VALE3Vale SA
R$ 51.52
(0.57%)
25.83M

Discussion

View Full Feed
Flobewan Flobewan 3 minutes ago
Marc loved your ides
tinojax tinojax 4 minutes ago
I usually enjoy a beer with my pizza............
PLUG
mrfence mrfence 7 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 23 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 23 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 24 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 25 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 31 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 34 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 40 minutes ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 41 minutes ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 45 minutes ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 45 minutes ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 52 minutes ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 52 minutes ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 55 minutes ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 57 minutes ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 58 minutes ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 1 hour ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 1 hour ago
Oh noooooo.....
FNMA
StockItOut StockItOut 1 hour ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 1 hour ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 1 hour ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL
Louinjaxxx Louinjaxxx 1 hour ago
The reversal on Friday just reflects the entire market downturn on Friday.
AXXA

Your Recent History

BOV
I1LM34
Illumina
BIT
UB8R00
Unicredit Bank
BIT
HZAR
Hsbc Msci South Africa C...
BOV
BOVAA500
BOVAA500 Ex:50
USOTC
HIHI
Holiday Island (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads